http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 06 Jul 2026 08:25:33 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,800.00) while maintaining a Underweight rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html Mon, 06 Jul 2026 08:25:33 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,800.00) while maintaining a Underweight rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html Mon, 06 Jul 2026 08:25:33 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,800.00) while maintaining a Underweight rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html Mon, 06 Jul 2026 08:25:33 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,800.00) while maintaining a Underweight rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+JPMorgan/26733139.html Mon, 06 Jul 2026 08:25:33 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Sell+Rating+on+Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29/26649354.html <p>Goldman Sachs analyst Akinori Ueda reiterated a Sell rating and JPY2,100.00 price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY).</p> http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Sell+Rating+on+Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29/26649354.html Tue, 16 Jun 2026 00:22:27 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Sell+Rating+on+Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29/26649354.html <p>Goldman Sachs analyst Akinori Ueda reiterated a Sell rating and JPY2,100.00 price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY).</p> http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Reiterates+Sell+Rating+on+Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29/26649354.html Tue, 16 Jun 2026 00:22:27 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Analyst+Comments/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Analyst+Comments/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Analyst+Comments/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html <p>Jefferies analyst Stephen Barker raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,500.00 (from JPY1,750.00) while maintaining a Hold rating.</p><p>The analyst comments "We trim near-term estimates to take account of one negative factor, the ending of a sales arrangement with AstraZeneca, but raise outer-year estimates to take account of several positive factors including the addition of ONO-280 for MSA to our estimates, following the announcement of Ph2 results. As a result, we raise our PT to ¥2,500 (from ¥1,750), but since this represents potential upside of only 5%, we reiterate Hold."</p> http://www.streetinsider.com/Analyst+Comments/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C500+at+Jefferies/26560784.html Thu, 28 May 2026 06:39:02 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,100.00 (from JPY1,900.00) while maintaining a Sell rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Mon, 11 May 2026 07:02:08 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,100.00 (from JPY1,900.00) while maintaining a Sell rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Mon, 11 May 2026 07:02:08 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,100.00 (from JPY1,900.00) while maintaining a Sell rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Mon, 11 May 2026 07:02:08 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,100.00 (from JPY1,900.00) while maintaining a Sell rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C100+at+Goldman+Sachs/26464838.html Mon, 11 May 2026 07:02:08 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,500.00) while maintaining a Sell rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Wed, 15 Apr 2026 08:15:32 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,500.00) while maintaining a Sell rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Wed, 15 Apr 2026 08:15:32 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,500.00) while maintaining a Sell rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Wed, 15 Apr 2026 08:15:32 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Goldman Sachs raised its price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,900.00 (from JPY1,500.00) while maintaining a Sell rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C900+at+Goldman+Sachs/26315414.html Wed, 15 Apr 2026 08:15:32 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,800.00 (from JPY1,500.00) while maintaining a Underweight rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html Wed, 15 Apr 2026 03:49:57 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,800.00 (from JPY1,500.00) while maintaining a Underweight rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html Wed, 15 Apr 2026 03:49:57 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,800.00 (from JPY1,500.00) while maintaining a Underweight rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html Wed, 15 Apr 2026 03:49:57 -0400 OPHLY http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html JPMorgan analyst Seiji Wakao raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY1,800.00 (from JPY1,500.00) while maintaining a Underweight rating. http://www.streetinsider.com/Analyst+PT+Change/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY1%2C800+at+JPMorgan/26313797.html Wed, 15 Apr 2026 03:49:57 -0400 OPHLY http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C400+at+NomuraInstinet/26086609.html Nomura/Instinet analyst Motoya Kohtani raised the price target on Ono Pharmaceutical Co., Ltd (4528:JP) (OTC: OPHLY) to JPY2,400.00 (from JPY1,800.00) while maintaining a Neutral rating. http://www.streetinsider.com/Intl+Ratings/Ono+Pharmaceutical+Co.%2C+Ltd+%284528%3AJP%29+%28OPHLY%29+PT+Raised+to+JPY2%2C400+at+NomuraInstinet/26086609.html Mon, 02 Mar 2026 06:53:27 -0400 OPHLY